LISA HAWLEY: Open Payments
NPI 1144321662 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 95 payments from 21 companies in 2025. Trend: 2023 $1,658 · 2024 $1,576 · 2025 $1,831
Food & beverage: $1,831
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 15 | $303 |
| GlaxoSmithKline, LLC. | 14 | $258 |
| ABBVIE INC. | 13 | $254 |
| Novo Nordisk Inc | 10 | $195 |
| PFIZER INC. | 10 | $171 |
| Exact Sciences Corporation | 6 | $119 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
| Lundbeck LLC | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
Products named: TRELEGY ELLIPTA, MOUNJARO, VRAYLAR, REXULTI, JARDIANCE, Rybelsus, NURTEC ODT, Cologuard Collection Kit.
Industry payments across MO — which companies pay providers there.
